Vicky Goh
Researcher
From Wikipedia, the free encyclopedia
Vicky Goh is a professor, chair of clinical cancer imaging, and head of cancer imaging department[1] at the King's College London, England, United Kingdom. She joined King's College London in 2011. She is also a consultant radiologist at Guy's and St Thomas' Hospital in London.[2]
Biography
Goh studied at Cheltenham Ladies' College, obtained a medical degree from University of Cambridge. She further trained at General Medicine and Radiology in London (UK) and University Health Network Hospitals in Toronto (Canada).[3] She has also worked as a Consultant Oncological Radiologist at Mount Vernon Hospital in the area of colorectal cancer.[4] She served as a president of the European Society of Oncologic Imaging in the past.[5] She is now a chair of the academic committee at the Royal College of Radiologists, and steering committee member of the European School of Radiology.[6]
She is interested in studying tumour heterogeneity, micro-environment, biomarker development in gastrointestinal, lung and renal cancers in humans using multi-modality functional imaging.[7] According to Scopus, she has published 209 scientific documents with 7233 citations, and an h-index of 45.[8] She has been mentioned on public online-blogs on several occasions for her cancer imaging work.[9][10][11] Her ORCID profile can be found here.[12]
Prof Goh is a deputy editor for the Radiology journal.[13]
Books edited
Chapters edited
- Multislice CT: edited by Konstantin Nikolaou, Fabian Bamberg, Andrea Laghi, Geoffrey D. Rubin.[17]
- Diffusion Weighted Imaging of the Gastrointestinal Tract: edited by Sofia Gourtsoyianni, Nikolaos Papanikolaou.[18]
- PET/MRI in Oncology: Current Clinical Applications. edited by Andrei Iagaru, Thomas Hope, Patrick Veit-Haibach.[19]
- Methods of Cancer Diagnosis, Therapy and Prognosis: Colorectal Cancer edited by M. A. Hayat.[20]
Selected publications
She has authored numerous publications. However, the following publications have more than 300 citations:
- 514 citations: Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?[21]
- 407 citations: Imaging biomarker roadmap for cancer studies.[22]
- 361 citations: Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.[23]
- 353 citations: Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis.[24]
- 331 citations: Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.[25]
- 326 citations: Are pretreatment 18F-FDG PET tumor textural features in non–small cell lung cancer associated with response and survival after chemoradiotherapy?[26]
- 306 citations: Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival.[27]
- 304 citations: Non–small cell lung cancer: histopathologic correlates for texture parameters at CT.[28]